ALBANY, New York, November 16, 2015 /PRNewswire/ --
According to a new market report published by Transparency Market Research "Autoimmune Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023," the global autoimmune disease diagnostics market was valued at US$12.3 bn in 2014 and is expected to grow at a CAGR of 3.8 % from 2015 to 2023, to reach an estimated value of US$17.1 bn in 2023.
Browse the full Autoimmune Disease Diagnostics Market report at: http://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html
Autoimmune disease diagnostics market includes various laboratory tests that are performed to diagnose autoimmune disorders. Diagnosis for these disorders include blood tests for one or more autoantibodies and tests for inflammation. The rising prevalence of autoimmune diseases, increase in healthcare expenditure globally, rapidly rising demand for autoimmune disease diagnostics and technical advances leading to advent of innovative diagnostic procedures with improved outcomes are some of the major factors expected to drive the market growth during the forecast period. According to the American Autoimmune Related Diseases Association (AARDA), autoimmune disease affects around 50 million people in the U.S. In addition, increasing automation in laboratories leading to higher sensitivity, faster and easy performance of the tests would further fuel the market of autoimmune disease diagnostics. However, slow turnaround time and high frequency of false positive results is expected to hamper the growth of autoimmune disease diagnostics market.
Get Sample Report Copy of Global Autoimmune Disease Diagnostics Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351
The market for autoimmune disease diagnostics is divided into eight segments on the basis of tests: antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, C-reactive protein test, erythrocyte sedimentation rate, urinalysis and others. Among these segments, autoantibody tests accounted for the largest market share in 2014 in terms of revenue and continues to dominate the market during the forecast period. Autoantibody tests are performed on patients with chronic, progressive arthritic symptoms, fatigue, fever, and muscle weakness. This test helps in the diagnosis of autoimmune disorders and used to evaluate and monitor effectiveness of treatment and relapses of the disorder. An article published by the American Association for Clinical Chemistry, stated that over 32 million people in the U.S. have autoantibodies, with antinuclear antibody the most prevalent and common type of antibodies present among women, older individuals, and African-Americans. Thus, the increasing number of people suffering from autoimmune disorders would fuel the market growth during the forecast period. The leadership of autoantibody tests segment was primarily observed due to high sensitivity and specificity. In addition, the main advantages of antibody-based tests are their speed, simplicity, and minimal patient discomfort.
Based on disease type, the autoimmune disease diagnostics market is categorized into seven segments: Graves' disease, Hashimotos's thyroiditis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus and others. Rheumatoid arthritis accounted for the largest market share in 2014 in terms of revenue and continues to dominate the market during the forecast period due to the rising prevalence of rheumatoid arthritis across the world and improved laboratory tests for the diagnosis of rheumatoid arthritis. According to the National Health Services, around 400,000 people in the U.K. are affected by rheumatoid arthritis. Moreover, entanglement of expensive assessment test such as magnetic resonance imaging (MRI) and X-rays in the rheumatoid disease is also a factor fueling the growth of rheumatoid arthritis disease diagnostics market.
Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio- Rad laboratories, bioMerieux and Siemens Healthcare are some of the major players operating in the global autoimmune disease diagnostics market.
Browse Press Release of Autoimmune Disease Diagnostics Market: http://www.transparencymarketresearch.com/pressrelease/autoimmune-disease-diagnostics-market.htm
The global autoimmune disease diagnostics market is segmented as follows:
Global Autoimmune Disease Diagnostics Market, by Test Type
- Antinuclear Antibody Tests
- Autoantibody Tests
- Complete Blood Count (CBC)
- Comprehensive Metabolic Panel
- C - reactive protein (CRP)
- Erythrocyte Sedimentation Rate (ESR)
Global Autoimmune Disease Diagnostics Market, by Disease Type
- Graves' Disease
- Hashimoto's Thyroiditis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (lupus)
- Type 1 diabetes
Global Autoimmune Disease Diagnostics Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East
Other Reports Published by Transparency Market Research:
- Internal Fixation Devices to Remain Keystone of Global Spinal Trauma Devices Market: http://www.transparencymarketresearch.com/spinal-trauma-devices-market.html
- Fragment-based Drug Discovery Market Expected to Reach USD 1.2 Billion Globally in 2023: http://www.transparencymarketresearch.com/fragment-based-drug-discovery-market.html
Browse All Other Pharmaceutical Market Research Reports: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
SOURCE Transparency Market Research Pvt. Ltd